Veracyte, Inc.
VCYT
$46.41
$0.140.30%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 25.49M | 28.71M | 41.15M | 19.14M | -980.00K |
| Total Depreciation and Amortization | 4.84M | 5.43M | 5.30M | 5.27M | 5.49M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 13.76M | 12.81M | 658.00K | 13.97M | 26.82M |
| Change in Net Operating Assets | 1.74M | -11.73M | 5.48M | 6.38M | 2.27M |
| Cash from Operations | 45.83M | 35.22M | 52.58M | 44.76M | 33.61M |
| Capital Expenditure | -2.86M | -2.96M | -3.78M | -2.79M | -1.29M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -2.85M | -- | -- |
| Other Investing Activities | -10.69M | -125.00M | 1.20M | 51.06M | 1.06M |
| Cash from Investing | -13.55M | -127.96M | -5.43M | 48.26M | -224.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 8.43M | 2.74M | 3.51M | 5.79M | 1.81M |
| Repurchase of Common Stock | -4.29M | -9.36M | -3.66M | -2.81M | -2.38M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 4.14M | -6.63M | -149.00K | 2.98M | -566.00K |
| Foreign Exchange rate Adjustments | -26.00K | -58.00K | 12.00K | 60.00K | 573.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 36.39M | -99.43M | 47.02M | 96.06M | 33.39M |